Ad
BOLD Short Information Audentes Therapeutics Inc.
home / stock / bold / bold short
Short Information | Audentes Therapeutics Inc. (NASDAQ:BOLD)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 267,115 |
| Total Actual Volume | 2,475,045 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 13,356 |
| Average Short Percentage | 17.11% |
Is there a BOLD Short Squeeze or Breakout about to happen?
See the BOLD Short Analysis for free Sign up or Login
Powered by Squeeze Report
BOLD Twenty Trading Day's Volume to Short Volume Chart
BOLD Twenty Trading Day Price Chart
BOLD Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-14-2025 | $2.35 | $2.3 | $2.5799 | $2.25 | 89,831 | 26,718 | 29.74% |
| 01-13-2025 | $2.5 | $2.25 | $2.6 | $2.19 | 86,811 | 11,082 | 12.77% |
| 01-10-2025 | $2.4143 | $2.42 | $2.51 | $2.32 | 65,537 | 15,175 | 23.15% |
| 01-08-2025 | $2.6 | $2.5 | $2.62 | $2.5 | 32,250 | 6,018 | 18.66% |
| 01-07-2025 | $2.76 | $2.62 | $2.76 | $2.5601 | 44,215 | 7,046 | 15.94% |
| 01-06-2025 | $2.75 | $2.7 | $2.77 | $2.65 | 50,826 | 8,186 | 16.11% |
| 01-03-2025 | $2.76 | $2.68 | $2.8 | $2.66 | 43,063 | 5,642 | 13.1% |
| 01-02-2025 | $2.88 | $2.73 | $3.12 | $2.705 | 69,273 | 9,765 | 14.1% |
| 12-31-2024 | $2.76 | $2.9 | $2.94 | $2.76 | 64,070 | 8,112 | 12.66% |
| 12-30-2024 | $2.53 | $2.69 | $2.76 | $2.53 | 45,485 | 6,056 | 13.31% |
| 12-27-2024 | $2.65 | $2.55 | $2.67 | $2.5 | 43,797 | 9,487 | 21.66% |
| 12-26-2024 | $2.54 | $2.65 | $2.77 | $2.5012 | 53,361 | 11,632 | 21.8% |
| 12-24-2024 | $2.52 | $2.58 | $2.615 | $2.375 | 44,582 | 10,628 | 23.84% |
| 12-23-2024 | $2.66 | $2.56 | $2.73 | $2.51 | 193,756 | 18,255 | 9.42% |
| 12-20-2024 | $2.48 | $2.59 | $2.86 | $2.48 | 972,395 | 19,035 | 1.96% |
| 12-19-2024 | $2.59 | $2.52 | $2.73 | $2.38 | 195,618 | 14,945 | 7.64% |
| 12-18-2024 | $2.615 | $2.5 | $2.84 | $2.48 | 71,838 | 14,025 | 19.52% |
| 12-17-2024 | $2.52 | $2.53 | $2.645 | $2.46 | 46,716 | 9,901 | 21.19% |
| 12-16-2024 | $2.5 | $2.51 | $2.64 | $2.42 | 68,168 | 17,826 | 26.15% |
| 12-13-2024 | $2.84 | $2.46 | $2.84 | $2.46 | 193,453 | 37,581 | 19.43% |
News, Short Squeeze, Breakout and More Instantly...
Audentes Therapeutics Inc. Company Name:
BOLD Stock Symbol:
NASDAQ Market:
Audentes Therapeutics Inc. Website:
Ad
-
Company elects not to advance BBI-825 into Part 2 portion of STARMAP clinical trial Third ecDTx program advancing, with plans for development candidate nomination by mid-2025 Operating runway extended into 2027, through anticipated clinical readout for BBI-355 and key development ...
-
SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary ...
-
Enrollment progressing in BBI-355 POTENTIATE and BBI-825 STARMAP clinical trials, with initial proof-of-concept data expected in the second half of 2025 Cash position of $167 million, with operating runway into the fourth quarter of 2026 SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ...